Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 129Neoplasm Metastasis 33Glioblastoma 24Melanoma 22Lung Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 15Glioma 12Small Cell Lung Carcinoma 8Neoplasms 8Gliosarcoma 8Central Nervous System Neoplasms 7Neuroma, Acoustic 6Meningioma 6Carcinoma, Renal Cell 6Astrocytoma 5Spinal Cord Neoplasms 4Recurrence 4Sarcoma 3Oligodendroglioma 3Gastrointestinal Neoplasms 3Breast Neoplasms, Male 3Uveal Melanoma 2Radiation Injuries 2Prostatic Neoplasms 2Kidney Neoplasms 2Fatigue 2Depression 2Colorectal Neoplasms 2Anxiety Disorders 2

Interventions

XENP 1595 2Cancer Vaccines 2Bevacizumab 2Adjuvants, Immunologic 2veliparib 1glutathione pegylated liposomal doxorubicin 1etoposide phosphate 1elacestrant 1binimetinib 1abemaciclib 1Trastuzumab 1Tissue Banks 1Temozolomide 1Radiotherapy 1Radiosurgery 1Radiation 1RAD1901 1Patient Discharge 1PF-07284890 1Midazolam 1Etoposide 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × Radiosurgery × CNS × Clear all
NCT05270707 2025-09-24

HyperArc Registry Study

Varian, a Siemens Healthineers Company

Completed
968 enrolled
CNS

Brain Diseases, Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡